Navigation Links
MedImmune To Present Eight Abstracts on Projects Regarding Thoracic and Respiratory Issues at the Annual American Thoracic Society International Conference

GAITHERSBURG, Md., May 13, 2011 /PRNewswire/ -- MedImmune announced today it will present eight abstracts at the American Thoracic Society (ATS) International Conference in Denver, CO, May 13-18, 2011.  "These data advance our understanding of thoracic diseases, highlighting our continued commitment to help improve patient health," said Bing Yao, Senior Vice President and Leader of the RIA innovative Medicines Unit (iMED) at MedImmune.

MedImmune abstracts to be presented at the ATS International Conference include:

  • IL-1 Family Members Have Different Effects on the Innate Pro-inflammatory and Anti-viral Responses of Epithelial Cells to Rhinovirus. Briend E, et al. Poster Session: May 16, 2011 Time: 10:45 - 12:30 PM,  Colorado Convention Center Area J, Hall B (Upper Level)
  • Cytokine Profiling in Severe Asthma Sub-phenotypes Using Factor and Cluster Analysis. Desai D, et al. Poster Session: May 16, 2011 Time: 3 - 3:15 PM, HRD Ballroom A-B-C (3rd Level)
  • Expression Patterns of Interleukin-1 Receptor 1 in COPD Patients, Smokers and Never-smoking Control Subjects. Bergqyist A, et al. Poster Session: May 16, 2011 Time: 8:15 AM – 4:30 PM, Colorado Convention Center Area E, Hall B (Upper Level)
  • Full Length IL-33 Activates Primary Human Mast Cells and It's Inhibited by Neutralising Antibodies. Cohen S, et al. Poster Session: May 17, 2011 Time: 8:15 AM – 4:30 PM, Colorado Convention Center Area F, Hall B (Upper Level)
  • The Epithelial-derived Signals TSLP, IL-25 and IL-33 Converge on OX40L to Elicit House-dust Mite 0 Induced Allergic Airway Inflammation in Mice. Llop-Guerva A, et al. Poster Session: May 16, 2011 Time: 8:15 AM – 4:30 PM, Colorado Convention Center Area K, Hall B (Upper Level)
  • In Vitro Cellular Response to Respiratory Syncytial Virus and Human Rhinovirus Infection of Primary Human Airway Epithelial Cells Derived From Healthy and COPD/Asthmatic Donors. Svabek C, et al. Poster Session: May 15, 2011 Time: 8:15 AM – 4:30 PM, Colorado Convention Center Area J, Hall B (Upper Level)
  • Comparison of the Preventative, Therapeutic and Prophylactic Effects of Anti-g and Anti-f RSV Glycoprotein Antibodies in the Response to Primary and Secondary RSV Infection. Han J, et al. Poster Session: May 18, 2011 Time: 2 – 4:30 PM, Colorado Convention Center Rooms 503-504 (Street Level)
  • Longitudinal Measures of Pulmonary Function in Healthy Late Preterm Infants Delivered at 33-36 Weeks of Gestation. McEvoy C, et al. Poster Session: May 16, 2011 Time: 2 – 4:30 PM, Colorado Convention Center Rooms 501-502 (Street Level)

Additional information about the 2011 ATS conference can be found at:

About MedImmune

MedImmune, the global biologics business for AstraZeneca PLC (LSE: AZN.L, NYSE: AZN), has approximately 3,500 employees worldwide and is headquartered in Gaithersburg, Maryland. With an advancing pipeline of promising drug candidates, MedImmune strives to deliver life-changing products, rewarding careers to our employees and a tireless commitment to improving patient health. For more information, visit MedImmune's website at

SOURCE MedImmune
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pfenex Announces Strategic Collaboration With MedImmune for the Use of Pfenex Expression Technology™
2. MedImmune to Present 11 Abstracts on Influenza at 45th Annual National Immunization Conference
3. MedImmune In-Licenses Clinical-Stage Anti-Inflammatory Monoclonal Antibody From Amgen
4. MedImmune Announces Winners of the 5th Annual Respiratory, Inflammation and Autoimmunity Research Abstract Competition
5. MedImmune Focused on Revolutionizing Cancer Care
6. MedImmune to Present Five Abstracts on RSV at Pediatric Academic Societies Annual Meeting
7. MedImmune to Present Data on RSV and Influenza at 2009 American Academy of Pediatrics National Conference & Exhibition
8. MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants
9. MedImmune Presents New Data Demonstrating Increased Risk for Medically Attended RSV in Late-Preterm Infants
10. MedImmune Advances Pediatric Disease Prevention Program With Start of Phase 1/2a Clinical Trial for Respiratory Syncytial Virus Vaccine
11. Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia
Post Your Comments:
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... ... , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize ... Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into ... Simply select a ProHand generator and drag it above media or text in the ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... On Friday, ... presented a Bronze Wellness at Work award to iHire in recognition of their exemplary ... part of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI ...
(Date:6/24/2016)... Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... surgery procedures that most people are unfamiliar with. The article goes on to state ... procedures, but also many of these less common operations such as calf and cheek ...
Breaking Medicine News(10 mins):